View in EDS PDF Full Text

Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.

Saved in:
Bibliographic Details
Title: Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.
Authors: Diamantopoulos, Panagiotis T.1, Kontandreopoulou, Christina-Nefeli1, Vassilakopoulos, Theodoros1, Siakantaris, Marina1, Angelopoulou, Maria1, Viniou, Nora-Athina1, Symeonidis, Argiris2, Solomou, Eleni2, Kourakli, Alexandra2, Christopoulou, Georgia2, Kotsianidis, Ioannis3, Pappa, Vassiliki4, Papageorgiou, Sotirios4, Galanopoulos, Athanasios5, Dimou, Maria6, Kyrtsonis, Marie-Christine6, Roumelioti, Maria6, Panayiotidis, Panayiotis6, Hellenic MDS Study Group (CORPORATE AUTHOR)
Source: Annals of Hematology. Jun2019, Vol. 98 Issue 6, p1383-1392. 10p.
Database: Academic Search Ultimate
Description
ISSN:09395555
DOI:10.1007/s00277-019-03650-w